Promising agents on the horizon

Abstract It is imperative that new therapeutic options be evaluated to identify those that may successfully circumvent chemoresistance in ovarian cancer and improve long-term outcomes. This chapter describes preclinical and clinical studies investigating novel therapies and potential preventive agents that may hold promise in future clinical applications in ovarian cancer treatment and control.